The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Heterogeneity of Monoclonal Antibodies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
Geiger, T., & Clarke, S. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75855-4 · Cited by 1,311
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Stability of Protein Pharmaceuticals
Manning, M. C., Patel, K., & Borchardt, R. T. (1989) · Pharmaceutical Research · doi:10.1023/a:1015929109894 · Cited by 1,078
Antibody Structure, Instability, and Formulation
Wang, W., Singh, S., Zeng, D. L., King, K., & Nema, S. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20727 · Cited by 941
Antibody Multispecificity Mediated by Conformational Diversity
James, L. C., Roversi, P., & Tawfik, D. S. (2003) · Science · doi:10.1126/science.1079731 · Cited by 719
Robinson, N. E., & Robinson, A. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.944 · Cited by 532
Glycosylation of Recombinant Antibody Therapeutics
Jefferis, R. (2008) · Biotechnology Progress · doi:10.1021/bp040016j · Cited by 526
Stephenson, R. C., & Clarke, S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83327-0 · Cited by 511
Cited by
Stability of Protein Pharmaceuticals: An Update
Manning, M. C., Chou, D. K., Murphy, B. M., Payne, R. W., & Katayama, D. S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-009-0045-6 · Cited by 1,098
Advances in recombinant antibody manufacturing
Kunert, R., & Reinhart, D. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7388-9 · Cited by 417
Higel, F., Seidl, A., Sörgel, F., & Friess, W. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.01.005 · Cited by 360
Dimitrov, D. S. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-921-1_1 · Cited by 347
Mass spectrometry for structural characterization of therapeutic antibodies
Zhang, Z., Pan, H., & Chen, X. (2009) · Mass Spectrometry Reviews · doi:10.1002/mas.20190 · Cited by 316
Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 Subclass
Dillon, T. M., Ricci, M. S., Vezina, C., Flynn, G. C., Liu, Y. D., Rehder, D. S., Plant, M., Henkle, B., Li, Y., Deechongkit, S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709988200 · Cited by 291
Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies
Du, Y., Walsh, A., Ehrick, R., Xu, W., May, K., & Liu, H. (2012) · mAbs · doi:10.4161/mabs.21328 · Cited by 291
Self-citationForced degradation of recombinant monoclonal antibodies: A practical guide
Nowak, C., K. Cheung, J., M. Dellatore, S., Katiyar, A., Bhat, R., Sun, J., Ponniah, G., Neill, A., Mason, B., Beck, A., et al. (2017) · mAbs · doi:10.1080/19420862.2017.1368602 · Cited by 260
Self-citationEon‐Duval, A., Broly, H., & Gleixner, R. (2012) · Biotechnology Progress · doi:10.1002/btpr.1548 · Cited by 234
Predicting antibody developability profiles through early stage discovery screening
Bailly, M., Mieczkowski, C., Juan, V., Metwally, E., Tomazela, D., Baker, J., Uchida, M., Kofman, E., Raoufi, F., Motlagh, S., et al. (2020) · mAbs · doi:10.1080/19420862.2020.1743053 · Cited by 228
Redman, E. A., Batz, N. G., Mellors, J. S., & Ramsey, J. M. (2015) · Analytical Chemistry · doi:10.1021/ac503964j · Cited by 136
Leblanc, Y., Ramon, C., Bihoreau, N., & Chevreux, G. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.02.017 · Cited by 127
Rolinger, L., Rüdt, M., & Hubbuch, J. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02407-z · Cited by 126
Dai, J., Lamp, J., Xia, Q., & Zhang, Y. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04608 · Cited by 123
Gahoual, R., Burr, A., Busnel, J.-M., Kuhn, L., Hammann, P., Beck, A., François, Y.-N., & Leize-Wagner, E. (2013) · mAbs · doi:10.4161/mabs.23995 · Cited by 90
Belov, A. M., Zang, L., Sebastiano, R., Santos, M. R., Bush, D. R., Karger, B. L., & Ivanov, A. R. (2018) · ELECTROPHORESIS · doi:10.1002/elps.201800067 · Cited by 88
Brunner, M., Fricke, J., Kroll, P., & Herwig, C. (2017) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-016-1693-7 · Cited by 79
Jin, Y., Lin, Z., Xu, Q., Fu, C., Zhang, Z., Zhang, Q., Pritts, W. A., & Ge, Y. (2019) · mAbs · doi:10.1080/19420862.2018.1525253 · Cited by 68
Charge variant analysis of proposed biosimilar to Trastuzumab
Dakshinamurthy, P., Mukunda, P., Prasad Kodaganti, B., Shenoy, B. R., Natarajan, B., Maliwalave, A., Halan, V., Murugesan, S., & Maity, S. (2017) · Biologicals · doi:10.1016/j.biologicals.2016.12.006 · Cited by 58
Hong, J. K., Lee, S. M., Kim, K.-Y., & Lee, G. M. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5596-8 · Cited by 46
Xie, P., Niu, H., Chen, X., Zhang, X., Miao, S., Deng, X., Liu, X., Tan, W.-S., Zhou, Y., & Fan, L. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7749-4 · Cited by 38
Zhuang, C., Zheng, C., Chen, Y., Huang, Z., Wang, Y., Fu, Q., Zeng, C., Wu, T., Yang, L., & Qi, N. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8312-7 · Cited by 16
Metadata
- Authors
- Liu, H., Gaza-Bulseco, G., Faldu, D., Chumsae, C., & Sun, J.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 97
- Issue
- 7
- Pages
- 2426-2447
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2048814278
- Cited by
- 481
- References
- 174
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.